UR’s new Faculty of Informatics and Data Science conducts research at the interface of a wide range of different disciplines, including medicine, biology, and business economics.
How can interdisciplinary and multiscalar approaches be used to better understand spatially distinct cultural systems as well as global interconnectivity? Researchers in Regensburg are leading the way in looking for answers.
SciFiMed is a multi-disciplinary project that combines fundamental immunological research with novel nanomaterial biosensor development translated into proof-of-principle diagnostics. International experts as well as biotechnology enterprises and health institutions are involved in the project.
Theological findings on apocryphal writings: Could they foster conflict resolution? Yes they could, say scholars at the Regensburg Centre for Advanced Studies Beyond Canon_.
At RCI, the Regensburg Center for Interventional Immunology, international research groups develop immunotherapies and cellular therapies in order to help treating patients suffering from tumors, chronic inflammation or autoimmunity.
Rupert Huber’s experimental work in terahertz and solid-state physics at the interface of optics and electronics is internationally renowned. His fundamental research is used in ultrafast atomic-resolution microscopes and quantum information processing.
Regulatory T cells (Tregs), a specialized type of immune cells, are usually seen as “peacekeepers” that prevent excessive immune attacks. Surprisingly, a new study published in “Signal Transduction and Targeted Therapy” shows that Tregs utilize inflammatory signals to start repair processes following cancer therapy. The research conducted by the LIT Cooperation Group “Innate Immune Sensing in Cancer and Transplantation” in cooperation with researchers from the Department of Radiation Oncology at the Technical University of Munich (TUM) uncovers how the body`s own immune system can be harnessed to repair the intestinal lining and improve survival.
Funding for chemical catalysis research
Patients receiving intensive cancer treatments - such as radiation or stem cell transplantation - often suffer from severe damage to the intestinal lining. This not only causes pain and complications but also worsens long-term outcomes. A “Nature Communications” study from the LIT Cooperation Group “Innate Immune Sensing in Cancer and Transplantation” reveals how a microbial metabolite safeguards the intestinal barrier and drives stem cell-mediated regeneration after injury. The results also show that the microbial product simultaneously reinforces the immune defense against leukemia.
A new study reveals the key features we use to recognize and categorize everyday behavior
